SAA1 is a major acute-phase serum amyloid A in humans.
Polymorphism of the SAA1 gene is associated with disease disposition.
The use of a chimeric recombinant SAA in some studies has raised concerns.
SAA1 transgenic and knockout mice have been generated for in vivo studies.
Recent studies have shown regulatory and homeostatic functions of SAA1.